$60 Million Paid By GlaxoSmithKline To Settle Lawsuits Over Drug Avandia
Settlement to close over 700 lawsuits linking Avandia to heart attacks and strokes
Bloomberg Business Week reports the largest drug maker in the U.K., GlaxoSmithKline (Glaxo), has agreed to pay $60 million in the first settlements of lawsuits over their drug, Avandia. This diabetes drug has been cited as causing heart attacks and strokes in some of the users.
This settlement will resolve more than 700 Avandia lawsuits, paying out about $86,000 for each case. Glaxo is scheduled to face its first Avandia trial in July in Philadelphia. More than 4,000 lawsuits have already been filed with more expected.
Avandia was approved for sale in the U.S. in 1999 and was the world’s best-selling diabetes pill before the safety concerns came out. Glaxo says the users who suffered heart attacks cannot link them to Avandia and no health risks were hidden.
Prescription drugs can have serious side effects. Munley, Munley & Cartwright has many successful years experience in prescription drug liability cases. If you or someone you care about has been injured or killed by an unsafe prescription drug, call us today at 1-800-318-LAW1 or contact us online for a free evaluation of your unique case.
Share this post: